Pregnancy, High Risk Clinical Trial
Official title:
Early Detection of Gestational Diabetes Mellitus in Pregnancy: A Randomized Trial
The purpose of this study is to develop an implementation protocol and test the feasibility and acceptability of a first trimester screening protocol for the early detection of gestational diabetes mellitus (GDM).
Gestational diabetes mellitus (GDM) is an important contributor to both maternal and neonatal morbidity and mortality in pregnancy. GDM has lifelong complications including an increased risk of developing type 2 diabetes mellitus and cardiovascular disease for women, and their offspring are at higher risk of being obese and also having diabetes in childhood and adolescence. Approximately 1 in 8 pregnancies is impacted by gestational diabetes mellitus worldwide. First trimester GDM screening is varied due to conflicting national guidelines, and the best strategy is unknown. The goal of the proposed research is to develop an implementation protocol and test the feasibility and acceptability of a first trimester screening protocol for the early detection of GDM. The investigators will utilize a pilot randomized controlled trial to recruit 80 high-risk pregnant women in the first trimester, of whom half will receive protocolized early GDM screening with serum biomarkers before 12 weeks and the remaining half will receive the current standard of care with screening between 24 and 28 weeks of gestation with possible early screening based on provider discretion. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03651843 -
Perception of Risks Into Work During Pregnancy Among Post-partum Women in the Lille Metropolis
|
||
Active, not recruiting |
NCT05656352 -
Validation of a Non-invasive Hemoglobin Measurement Device in Pregnancy and Postpartum in Kenya, Pakistan, and Zambia
|
||
Not yet recruiting |
NCT06430853 -
Psychobiological Interventions in Pregnancy
|
N/A | |
Completed |
NCT05316415 -
The Effects of Music on the Anxiety and Sleep Quality of Pregnant Women on Bed Rest for a High-risk Pregnancy
|
N/A | |
Not yet recruiting |
NCT03985618 -
The MODE Trial: Planned Caesarean Section Versus Induction of Labour for Women With Class III Obesity
|
N/A | |
Completed |
NCT02008097 -
Clinical Benefits of B-Flow Ultrasound
|
N/A | |
Recruiting |
NCT05922033 -
Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)
|
Phase 4 | |
Completed |
NCT03413631 -
A Prenatal Mentalization-focused 4D Ultrasound and a Pregnancy Diary Intervention for Substance-abusing Women
|
N/A | |
Not yet recruiting |
NCT05317585 -
Continuous Glucose Monitor Use in Pregnancy
|
N/A | |
Recruiting |
NCT04861103 -
Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)
|
Phase 4 | |
Completed |
NCT03334149 -
Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension
|
N/A | |
Completed |
NCT03646487 -
A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Women
|
N/A | |
Recruiting |
NCT05198206 -
Pregnant Women With Pulmonary Hypertension in China
|
||
Recruiting |
NCT05739123 -
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
|
||
Recruiting |
NCT05807256 -
Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
|
||
Completed |
NCT04874285 -
Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.
|
N/A | |
Not yet recruiting |
NCT05662462 -
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
|
N/A | |
Recruiting |
NCT03975894 -
TAPS2 Transfusion Antenatally in Pregnant Women With SCD
|
Phase 2 | |
Recruiting |
NCT05597943 -
mHealth Smartphone App and Postpartum Glucose Intolerance for Patients With GDM
|
N/A | |
Recruiting |
NCT04924504 -
Mechanisms Behind Severe Insulin Resistance During Pregnancy in Women With Glucose Metabolic Disorders (SIR-MET)
|